Drug
CG 7321
CG 7321: highest development phase Phase 1, developed by Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| CG-7321 NCT07923214 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow CG 7321 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.